Pan‐cancer analysis of RPL36A expression revealed significant differences across various tumour types, including hepatocellular carcinoma, breast cancer, colon cancer and NSCLC, compared to normal tissues (Figure 7D). This evidence concerns the gene RPL36A and neoplasm.